Biotechnology

AI-Designed Vaccine Completes Historic Human Trials

A historic AI-designed vaccine has passed human trials, targeting multiple coronaviruses with no significant side effects noted.

Meta's Strategic Focus: Winning the AI Race through Health Technology

Meta prioritizes health in AI development, aiming for practical applications over raw performance, as indicated by its Muse Spark model.

Biopharma M&A Points to a Durable Deal Cycle

Biopharma M&A more than doubled in 2025 and kept accelerating into Q1 2026. Patent cliff pressure and undervalued biotech assets suggest the deal cycle has room to run.

AI Leaders Call for Regulation on Synthetic DNA Supply Chain to Mitigate Biological Risks

AI leaders urge US Congress to regulate synthetic DNA supply, addressing risks of AI-assisted biological threats.

Exploring the Complex Interplay of Mathematics, AI, and Human Identity

Uncover the profound connection between mathematics, AI, and human identity, and explore the ethical implications of technological advancements.

Brian Armstrong’s Vision for Curing Aging with Biotech Innovation

Brian Armstrong is leading a biotech firm aiming to reverse aging with substantial venture funding and innovative cellular research.

Microsoft Discovery: Pioneering AI in Scientific Research

Microsoft Discovery revolutionizes scientific research with AI-driven workflows and partnerships, enhancing efficiency and innovation.

OpenAI's Strategic Initiatives in Biodefense: An Investor's Perspective

OpenAI initiates biodefense efforts with investments, partnerships, and AI models to strengthen pandemic preparedness and response.

OpenAI's Strategic Investments in Biodefense: A New Frontier for AI and Life Sciences

OpenAI is investing in biodefense startups and developing AI tools to detect biological threats, emphasizing safety and collaborative efforts.

Biohub Unveils Game-Changing Open-Source Toolkit for Protein Science

Biohub's groundbreaking open-source toolkit for protein research signifies a major advancement in biotechnology and drug discovery.

Bristol Myers Squibb's Revolutionary AI Partnership with Anthropic

Bristol Myers Squibb partners with Anthropic for a groundbreaking AI deployment, impacting 30,000 employees and transforming pharmaceutical operations.

Isomorphic Labs Secures $2.1 Billion as AI Transforms Drug Discovery

Isomorphic Labs has raised $2.1 billion to advance its drug design capabilities using AI, aiming for clinical trials to revolutionize pharmaceuticals.

AstraZeneca (NYSE: AZN) Posts Revenue Above $15bn in Q1

AstraZeneca reported Q1 2026 total revenue of $15.3bn, up 8% at constant exchange rates, as oncology and rare disease offset CVRM declines.

Iran's Use of Foreign Militias Signals Strain on Regime Stability

Iran's regime's dependency on foreign militias indicates a decrease in likely protests. Current market odds show 7.5% chance of regime change.

Exploring the Transformative Potential of GLP-1 Medicines and Their Impact on Public Health

GLP-1 medicines are set to exceed $100 billion in revenue, signaling a major revolution in public health and investment opportunities.